Swainsonine |
Lysosomal α-1-3- (IC50 0.70 nM) and α-1-6-mannosidase (Ki 40 nM) and Golgi α-mannosidase |
Inhibits growth of tumor cells |
[13] |
1,4-Dideoxy-1,4-imino-D-mannitol |
α-mannosidase, Lysosomal Golgi α-mannosidase II, glycogen phosphorylase |
Human Glioblastoma and Melanoma Cells |
[74] |
1-Deoxymannojirimycin |
α-1-2-mannosidase (IC50 0.02 mM), Golgi α-mannosidase II (IC50 400 µM) |
Interact with recombinant tumor necrosis factor (rTNF) and recombinant interleukin 1 (rIL-1) |
[75] |
2-aminomethyl-5-(hydroxymethyl) pyrrolidine3,4-diol derivative |
Jack bean α-Mannosidase (IC50 55 µM) |
Inhibits growth of human glioblastoma cells and melanoma cells, DNA, synthesis of proteins |
[74,76] |
Castanospermine |
α- and β-glucosidases |
Inhibitor of breast cancer |
[77] |
1-deoxynojirimycin |
Glucosidase I and II |
Anti-metastatic activity, reduce adhesion of tumor cells to vascular endothelium, inhibit cellular transformation, prevent morphological differentiation of endothelial cells |
[13] |
(+)-Lentiginosine |
amyloglucosidases |
Inhibits ATPase and Chaperone Activity of Hsp90 |
[78] |
Siastatin B |
β-glucuronidase, NAG-ase |
Antimetastatic activity |
[13] |